Gender and C-reactive protein

Data from the Multiethnic Study of Atherosclerosis (MESA) cohort

Susan G. Lakoski, Mary Cushman, Michael Criqui, Tatjana Rundek, Roger S. Blumenthal, Ralph B. D'Agostino, David M. Herrington

Research output: Contribution to journalArticle

187 Citations (Scopus)

Abstract

Background: American Heart Association/Centers for Disease Control and Prevention guidelines support the measurement of C-reactive protein (CRP) to further risk stratify individuals at intermediate risk (10%-20% 10-year risk) for heart disease. Determining gender-specific differences in CRP may alter how CRP levels are interpreted and used to determine risk. Methods: MESA is a prospective cohort consisting of 6814 men and women aged 45 to 84 years recruited from 6 US communities. Nonparametric analyses were performed to determine differences in CRP levels by gender in the entire cohort and after stratifying by use of estrogen medication (n = 944). Stratifying by median body mass index (BMI) and generalized linear models were also used to account for confounding variables associated with CRP. Results: Overall, women had substantially higher median CRP levels compared with men (2.56 vs 1.43 mg/L, P < .0001). After excluding women using estrogen and individuals with CRP >10 mg/L, median CRP levels remained higher in women compared with men (1.85 vs 1.33 mg/L, P < .0001). When participants were stratified into high and low BMI groups, the gender difference in CRP levels remained. This pattern of higher CRP levels in women was consistent across all ethnic subgroups even after multivariable adjustment. Conclusions: C-reactive protein levels were higher in women compared with men despite accounting for BMI and other common confounding variables. This gender difference was maintained across all ethnic subgroups. These results suggest that evaluation of gender-specific CRP cut points to determine cardiovascular risk should be considered.

Original languageEnglish
Pages (from-to)593-598
Number of pages6
JournalAmerican Heart Journal
Volume152
Issue number3
DOIs
StatePublished - Sep 1 2006
Externally publishedYes

Fingerprint

C-Reactive Protein
Atherosclerosis
Cohort Studies
Body Mass Index
Confounding Factors (Epidemiology)
Centers for Disease Control and Prevention (U.S.)
Linear Models
Heart Diseases
Estrogens
Guidelines

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lakoski, S. G., Cushman, M., Criqui, M., Rundek, T., Blumenthal, R. S., D'Agostino, R. B., & Herrington, D. M. (2006). Gender and C-reactive protein: Data from the Multiethnic Study of Atherosclerosis (MESA) cohort. American Heart Journal, 152(3), 593-598. https://doi.org/10.1016/j.ahj.2006.02.015

Gender and C-reactive protein : Data from the Multiethnic Study of Atherosclerosis (MESA) cohort. / Lakoski, Susan G.; Cushman, Mary; Criqui, Michael; Rundek, Tatjana; Blumenthal, Roger S.; D'Agostino, Ralph B.; Herrington, David M.

In: American Heart Journal, Vol. 152, No. 3, 01.09.2006, p. 593-598.

Research output: Contribution to journalArticle

Lakoski, SG, Cushman, M, Criqui, M, Rundek, T, Blumenthal, RS, D'Agostino, RB & Herrington, DM 2006, 'Gender and C-reactive protein: Data from the Multiethnic Study of Atherosclerosis (MESA) cohort', American Heart Journal, vol. 152, no. 3, pp. 593-598. https://doi.org/10.1016/j.ahj.2006.02.015
Lakoski, Susan G. ; Cushman, Mary ; Criqui, Michael ; Rundek, Tatjana ; Blumenthal, Roger S. ; D'Agostino, Ralph B. ; Herrington, David M. / Gender and C-reactive protein : Data from the Multiethnic Study of Atherosclerosis (MESA) cohort. In: American Heart Journal. 2006 ; Vol. 152, No. 3. pp. 593-598.
@article{33e8c500574940b388917ce84b797285,
title = "Gender and C-reactive protein: Data from the Multiethnic Study of Atherosclerosis (MESA) cohort",
abstract = "Background: American Heart Association/Centers for Disease Control and Prevention guidelines support the measurement of C-reactive protein (CRP) to further risk stratify individuals at intermediate risk (10{\%}-20{\%} 10-year risk) for heart disease. Determining gender-specific differences in CRP may alter how CRP levels are interpreted and used to determine risk. Methods: MESA is a prospective cohort consisting of 6814 men and women aged 45 to 84 years recruited from 6 US communities. Nonparametric analyses were performed to determine differences in CRP levels by gender in the entire cohort and after stratifying by use of estrogen medication (n = 944). Stratifying by median body mass index (BMI) and generalized linear models were also used to account for confounding variables associated with CRP. Results: Overall, women had substantially higher median CRP levels compared with men (2.56 vs 1.43 mg/L, P < .0001). After excluding women using estrogen and individuals with CRP >10 mg/L, median CRP levels remained higher in women compared with men (1.85 vs 1.33 mg/L, P < .0001). When participants were stratified into high and low BMI groups, the gender difference in CRP levels remained. This pattern of higher CRP levels in women was consistent across all ethnic subgroups even after multivariable adjustment. Conclusions: C-reactive protein levels were higher in women compared with men despite accounting for BMI and other common confounding variables. This gender difference was maintained across all ethnic subgroups. These results suggest that evaluation of gender-specific CRP cut points to determine cardiovascular risk should be considered.",
author = "Lakoski, {Susan G.} and Mary Cushman and Michael Criqui and Tatjana Rundek and Blumenthal, {Roger S.} and D'Agostino, {Ralph B.} and Herrington, {David M.}",
year = "2006",
month = "9",
day = "1",
doi = "10.1016/j.ahj.2006.02.015",
language = "English",
volume = "152",
pages = "593--598",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Gender and C-reactive protein

T2 - Data from the Multiethnic Study of Atherosclerosis (MESA) cohort

AU - Lakoski, Susan G.

AU - Cushman, Mary

AU - Criqui, Michael

AU - Rundek, Tatjana

AU - Blumenthal, Roger S.

AU - D'Agostino, Ralph B.

AU - Herrington, David M.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Background: American Heart Association/Centers for Disease Control and Prevention guidelines support the measurement of C-reactive protein (CRP) to further risk stratify individuals at intermediate risk (10%-20% 10-year risk) for heart disease. Determining gender-specific differences in CRP may alter how CRP levels are interpreted and used to determine risk. Methods: MESA is a prospective cohort consisting of 6814 men and women aged 45 to 84 years recruited from 6 US communities. Nonparametric analyses were performed to determine differences in CRP levels by gender in the entire cohort and after stratifying by use of estrogen medication (n = 944). Stratifying by median body mass index (BMI) and generalized linear models were also used to account for confounding variables associated with CRP. Results: Overall, women had substantially higher median CRP levels compared with men (2.56 vs 1.43 mg/L, P < .0001). After excluding women using estrogen and individuals with CRP >10 mg/L, median CRP levels remained higher in women compared with men (1.85 vs 1.33 mg/L, P < .0001). When participants were stratified into high and low BMI groups, the gender difference in CRP levels remained. This pattern of higher CRP levels in women was consistent across all ethnic subgroups even after multivariable adjustment. Conclusions: C-reactive protein levels were higher in women compared with men despite accounting for BMI and other common confounding variables. This gender difference was maintained across all ethnic subgroups. These results suggest that evaluation of gender-specific CRP cut points to determine cardiovascular risk should be considered.

AB - Background: American Heart Association/Centers for Disease Control and Prevention guidelines support the measurement of C-reactive protein (CRP) to further risk stratify individuals at intermediate risk (10%-20% 10-year risk) for heart disease. Determining gender-specific differences in CRP may alter how CRP levels are interpreted and used to determine risk. Methods: MESA is a prospective cohort consisting of 6814 men and women aged 45 to 84 years recruited from 6 US communities. Nonparametric analyses were performed to determine differences in CRP levels by gender in the entire cohort and after stratifying by use of estrogen medication (n = 944). Stratifying by median body mass index (BMI) and generalized linear models were also used to account for confounding variables associated with CRP. Results: Overall, women had substantially higher median CRP levels compared with men (2.56 vs 1.43 mg/L, P < .0001). After excluding women using estrogen and individuals with CRP >10 mg/L, median CRP levels remained higher in women compared with men (1.85 vs 1.33 mg/L, P < .0001). When participants were stratified into high and low BMI groups, the gender difference in CRP levels remained. This pattern of higher CRP levels in women was consistent across all ethnic subgroups even after multivariable adjustment. Conclusions: C-reactive protein levels were higher in women compared with men despite accounting for BMI and other common confounding variables. This gender difference was maintained across all ethnic subgroups. These results suggest that evaluation of gender-specific CRP cut points to determine cardiovascular risk should be considered.

UR - http://www.scopus.com/inward/record.url?scp=33747193034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747193034&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2006.02.015

DO - 10.1016/j.ahj.2006.02.015

M3 - Article

VL - 152

SP - 593

EP - 598

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 3

ER -